Study Suggests Drug Treatment for ADHD Can Lower Risks
A recent study indicates that medication for individuals newly diagnosed with ADHD (attention deficit hyperactivity disorder) can significantly decrease risks associated with substance misuse, suicidal actions, transport accidents, and criminal behavior. These issues are often tied to typical ADHD symptoms, like impulsivity and distractibility.
Worldwide, around 5% of children and 2.5% of adults are believed to have ADHD, and the number of diagnoses is on the rise. The research published in the British Medical Journal (BMJ) highlights the broader benefits of medication, potentially guiding patients in deciding whether to initiate treatment.
ADHD affects brain function differently compared to most people. Symptoms may include trouble focusing, high energy levels, difficulty remaining still, and impulsiveness. Interestingly, while more people are seeking help, it doesn’t necessarily mean the disorder is becoming more prevalent. In fact, a previous BBC investigation revealed long wait times for assessments in the UK.
A diagnosis is typically made only when ADHD symptoms significantly impact daily living. Stimulants, the primary medications prescribed, are effective for managing day-to-day symptoms, yet evidence showing long-term behavior benefits has been limited. Side effects such as headaches, appetite loss, and sleep disturbances have raised concerns regarding their safety.
This BMJ study analyzed data from 148,500 individuals aged six to 64 in Sweden diagnosed with ADHD. Among them, 57% started medication, and 88% of those prescribed received methylphenidate (commonly known as Ritalin).
Researchers from the University of Southampton and the Karolinska Institute found that ADHD medication correlated with a reduction in first-time occurrences of several issues:
- 17% for suicidal behavior
- 15% for substance misuse
- 12% for transport accidents
- 13% for criminal behavior
When looking at recurring events, the study found even larger reductions:
- 15% for suicide attempts
- 25% for substance misuse
- 4% for accidental injuries
- 16% for transport accidents
- 25% for criminal behavior
Professor Samuele Cortese, one of the study’s authors and a professor of child and adolescent psychiatry at the University of Southampton, noted, “There often isn’t adequate information about the risks of not treating ADHD. This evidence shows that medications can help mitigate those risks.”
This effect might stem from medication’s ability to curb impulsive behavior and improve concentration, thus potentially reducing accidents while driving and minimizing aggressive behaviors linked to criminality. However, the researchers acknowledge that while their study aimed for robustness, factors like genetics, lifestyle, and the severity of ADHD might influence outcomes.
Access to appropriate ADHD medication can be quite challenging in many countries, with some facing shortages. In the UK, waiting periods to see specialists for drug access post-diagnosis can stretch for years.
Professor Stuart Kinner, leading the Justice Health Group at Curtin University in Western Australia, commented on the study’s findings, noting the far-reaching advantages of ADHD diagnosis and treatment. He pointed out that failing to diagnose and treat ADHD may lead to self-medication with substances like alcohol, poor mental health, injuries, and even incarceration. “Many individuals with undiagnosed ADHD find themselves involved in the criminal justice system without proper treatment or diagnosis,” he added.
Ian Maidment, a professor of clinical pharmacy at Aston University, remarked that this study enhances our understanding of the potential benefits of ADHD medications but highlighted that it did not evaluate whether patients adhered to their treatment regimens or the effects of varying doses.
